22-23 October, 2013 | Crowne Plaza, Princeton; New Jersey, USA
Global Discovery & Development Innovation Summit
Advance Pipelines. Overcome Bottlenecks.
Drive the Future of Pharma R&D.
In an age of looming patent cliffs, fading blockbusters and digital revolution, now is the time to review and evaluate drug discovery and development strategies, streamline, innovate and get to market faster. GDDIS is dedicated to scientific insights, technology innovation & strategy across the entire therapeutic development lifecycle
Welcome to GDDIS
No front page content has been created yet.
Welcome to GDDIS 2013
GDDIS is the leading annual R&D Summit for pharma decision makers, scientific leaders and solutions experts. GDDIS is dedicated to scientific insights, technology innovation & strategy across the entire therapeutic development lifecycle.
Evaluate, benchmark & network with over 150 fellow leaders at the 4th Annual Global Discovery to Development Innovation Summit.
What’s new this year?
3 conference streams allow you to personalize your conference experience: Cherry-pick the presentations you want to hear
An agenda designed by R&D luminaries from pharma, biotech and academia deliver an event that is truly focused on finding answers to the key questions facing drug discovery and development
Tackle a variety of key issues affective Pharma R&D: Get up to speed on thepersonalization of oncology drug development, capitalize on therise of big data, and harness the power of the genome
Representatives from the world’s biggest drug developers share a stage with their partners; Get real world evidence of partnership success
Over20 case studies from big pharma – exclusively C-Level, SVP and VP make this the most senior speaker line up of any R&D event
Over 3 hours of interactive panel sessions androundtable discussions get right to the heart of the most pressing issues in drug discovery, development and commercialization
The GBX Summits Family
The GBX Summits Family
6th-7th March, 2013
12th-13th February, 2013
22nd-23rd October, 2012
Summit Themes & Topics
» Leveragenovel technologies to reduce attrition and drive clear decision-making
» Examine the role of predictive biomarkers with in depth analysis and real-world case studies
» Harness advanced technologies & integrated strategies in data mining and analytics
» Build successful partnerships, manage alliances and gain/maintain a competitive advantage
» Accelerate the drug discovery process by keeping up to speed with key industry drivers and game-changers
» Hone drug development from end-to-end: From target validation through to clinical POC studies
» Evaluate and apply high-powered genomics techniques
Global Advisory Board
Director of Partnerships
David Geffen School of Medicine, UCLA
Director Discovery & Preclinical Research
Broad Institute of Harvard & MIT
Consultant, Office of the Center Director
Director of Cancer Biology
Chief Medical Officer
D. Leach, Ph.D.
MRL IT for Discovery & Preclinical Sciences
Summits Researched & Produced By
134 Tooley Street
London, SE1 2TU